Inflammation, depression and dementia: are they connected?
Chronic inflammation is now considered to be central to the pathogenesis not only of such medical disorders as cardiovascular disease, multiple sclerosis, diabetes and cancer but also of major depression. If chronic inflammatory changes are a common feature of depression, this could predispose depressed patients to neurodegenerative changes in later life. Indeed there is now clinical evidence that depression is a common antecedent of Alzheimer's disease and may be an early manifestation of dementia before the cognitive declines becomes apparent. This review summarises the evidence that links chronic low grade inflammation with changes in brain structure that could precipitate neurodegenerative changes associated with Alzheimer's disease and other dementias. For example, neuronal loss is a common feature of major depression and dementia. It is hypothesised that the progress from depression to dementia could result from the activation of macrophages in the blood, and microglia in the brain, that release pro-inflammatory cytokines. Such cytokines stimulate a cascade of inflammatory changes (such as an increase in prostaglandin E2, nitric oxide in addition to more pro-inflammatory cytokines) and a hypersecretion of cortisol. The latter steroid inhibits protein synthesis thereby reducing the synthesis of neurotrophic factors and preventing reairto damages neuronal networks. In addition, neurotoxic end products of the tryptophan-kynurenine pathway, such as quinolinic acid, accumulate in astrocytes and neurons in both depression and dementia. Thus increased neurodegeneration, reduced neuroprotection and neuronal repair are common pathological features of major depression and dementia. Such changes may help to explain why major depression is a frequent prelude to dementia in later life.
Leonard
Brian E
BE
Department of Psychiatry and Neuropsychology, Brain and Behaviour Research Institute, University of Maastricht, Maastricht, The Netherlands. belucg@iol.ie
D000544:Alzheimer Disease / Q000473:pathology; D003704:Dementia / Q000473:pathology*; D003866:Depressive Disorder / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000473:pathology*; D009498:Neurotoxins / Q000378:metabolism
D009498:Neurotoxins
Gen Hosp Psychiatry. 1987 Nov;9(6):426-34
3692149
J Neuroimmunol. 2000 Jan 3;102(1):8-16
10626661
Am J Psychiatry. 2003 Jul;160(7):1342-5
12832253
Neurotox Res. 2006 Oct;10(2):149-60
17062376
Neuron. 1994 Aug;13(2):487-94
7520256
Med Hypotheses. 1991 Aug;35(4):298-306
1943879
Neuropsychopharmacology. 2000 Apr;22(4):370-9
10700656
Am J Psychiatry. 2005 Apr;162(4):691-8
15800140
J Neurosci. 1998 Dec 15;18(24):10445-56
9852582
Brain Behav Immun. 2003 Aug;17(4):276-85
12831830
Neuropsychobiology. 1999 Nov;40(4):171-6
10559698
Neurobiol Aging. 2003 Nov;24(7):927-31
12928052
Nat Rev Drug Discov. 2002 Aug;1(8):609-20
12402501
Neuroscience. 1987 Nov;23 (2):423-32
2963969
Brain. 1993 Dec;116 ( Pt 6):1425-50
8293279
J Affect Disord. 2005 Oct;88(2):167-73
16126278
Biol Psychiatry. 2002 Aug 1;52(3):243-52
12182930
Adv Exp Med Biol. 1999;461:25-46
10442165
Arch Intern Med. 2004 May 10;164(9):1010-4
15136311
N Engl J Med. 2004 Jul 1;351(1):56-67
15229308
Neurosci Lett. 1993 Apr 16;153(1):13-16
8510817
Am J Psychiatry. 2002 Dec;159(12):2072-80
12450959
Neuropsychopharmacology. 2003 Jun;28(6):1182-5
12700687
Acta Psychiatr Scand. 2001 Mar;103(3):226-8
11240580
J Biol Chem. 2001 Aug 10;276(32):30142-9
11387343
Nature. 1995 Apr 13;374(6523):647-50
7715705
Biochem J. 1996 Dec 1;320 ( Pt 2):595-7
8973572
Neurosci Lett. 1999 May 28;267(2):81-4
10400217
Biol Psychiatry. 2005 Aug 1;58(3):190-6
16084839
Mol Psychiatry. 2002;7(5):468-73
12082564
Ann Neurol. 2000 Mar;47(3):361-5
10716256
Psychol Bull. 1993 May;113(3):472-86
8316610
Psychol Bull. 1993 Jan;113(1):23-43
8093981
Biol Psychiatry. 2005 Aug 1;58(3):175-89
16084838
J Clin Immunol. 1999 Jul;19(4):223-30
10471976
J Neuroimmunol. 1993 Jun;45(1-2):137-45
8392517
J Clin Psychiatry. 1990 Jun;51 Suppl:3-11; discussion 12-4
2189874
J Cell Biochem. 1993 Dec;53(4):314-22
8300749
Alzheimer Dis Assoc Disord. 1998 Sep;12(3):215-27
9772027
Science. 2003 Aug 8;301(5634):805-9
12907793
Free Radic Biol Med. 1997;23(1):134-47
9165306
Psychopharmacology (Berl). 2000 Nov;152(4):383-9
11140330
Med Hypotheses. 2003 Nov-Dec;61(5-6):519-25
14592780
Brain Behav Immun. 1996 Sep;10(3):260-74
8954598
Psychosom Med. 2000 Mar-Apr;62(2):188-96
10772396
Neurobiol Aging. 2002 Sep-Oct;23(5):655-64
12392766
J Neuroimmunol. 1999 Jan 1;93(1-2):139-48
10378877
J Psychiatr Res. 1999 Sep-Oct;33(5):407-18
10504009
FASEB J. 1999 Jan;13(1):63-8
9872930
Pharmacopsychiatry. 2006 May;39(3):88-99
16721697
Psychosom Med. 2003 Mar-Apr;65(2):194-200
12651986
Br J Psychiatry. 2000 Jun;176:568-75
10974964
Psychiatr Genet. 2003 Sep;13(3):179-81
12960751
Nature. 2004 Aug 5;430(7000):631-9
15295589
Neurosci Lett. 2002 Aug 2;328(1):71-3
12123862
Lancet. 2001 Feb 10;357(9254):436-9
11273064
Psychoneuroendocrinology. 2004 Oct;29(9):1119-28
15219635
Ann Intern Med. 2004 Apr 20;140(8):627-38
15096334
J Neurosci. 2000 Dec 15;20(24):9104-10
11124987
Immunol Today. 1991 Jul;12(7):217-9
1909530
J Neurochem. 2001 Aug;78(4):842-53
11520905
J Immunol. 2000 Aug 15;165(4):2232-9
10925311
Neurochem Int. 2007 Jan;50(2):308-13
17023091
Biol Psychiatry. 1997 Apr 15;41(8):851-6
9099411
Neuroscience. 1999 Mar;89(1):157-66
10051225
Psychol Med. 2003 May;33(4):667-74
12785468
Neurology. 1998 Apr;50(4):979-85
9566382
J Neurosci. 2004 Jan 14;24(2):319-28
14724230
J Affect Disord. 1994 Apr;30(4):283-8
7516941
Mol Psychiatry. 2005 Jun;10(6):538-44
15494706
Nat Cell Biol. 2001 Mar;3(3):E81-8
11231595
Psychiatry Res. 1996 Oct 16;64(3):161-7
8944394
Prog Neurobiol. 1998 Jan;54(1):71-85
9460794
Epidemiology. 2003 Jan;14(1):103-7
12500057
J Neurosci. 2005 Feb 2;25(5):1089-94
15689544
J Neurosci. 1995 May;15(5 Pt 1):3468-74
7538561